Understanding of IBD, its causes, prognosis and potential treatments will ultimately come from a ‘multi-omics’ approach, according to speakers at ECCO 2019. The current ‘reductionist’ approaches that focus on single areas such as the microbiome or inflammatory responses fail to capture the interplay of systems that undoubtedly underlie the range of diseases that make up ...
Why a multi-omics approach is the Holy Grail for IBD
By Michael Woodhead
21 Mar 2019